Does early closed-loop therapy preserve pancreas function in youth with type 1 diabetes? Medha Baranwal27 Dec 2022 11:15 AM ISTUK: Intensive glucose control for 24 months in adolescents with new-onset type 1 diabetes did not avert the decline in endogenous insulin secretion,...
Type 1 diabetes associated complications partly due to family related characteristics Jacinthlyn Sylvia22 Dec 2022 11:30 AM ISTSweden: A new study published in Diabetes Care found that the increased risk of melancholy, anxiety and stress-related illnesses in children and...
Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa Ruchika Sharma15 Dec 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and EVA Pharma have announced a collaboration to deliver a sustainable supply of high-quality,...
Quick release Bromocriptine may improve aortic stiffness in young diabetes 1 patients Dr.Niharika Harsha B14 Dec 2022 10:45 AM ISTBromocriptine quick release (BCQR) improves blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in adolescents with...
HbA1C to be lower than 7% to cut down complications in type 1 diabetes patients: Study Dr. Kamal Kant Kohli8 Dec 2022 10:00 AM ISTAccording to a new study HbA1C levels should be lower than 7% to cut down complications among patients of type 1 diabetes.People with diabetes may...
Personalized kidney screening in type 1 diabetes tied to early detection and reduced testing frequency Medha Baranwal7 Dec 2022 11:00 AM ISTUSA: Adopting a personalized approach alternative to annual screening for patients with type 1 diabetes (T1D) can considerably reduce the frequency of...
Rapid loss of C-peptide tied to risk of severe hypoglycemia in children with type 1 diabetes: Study Medha Baranwal20 Nov 2022 8:30 PM ISTSweden: A rapid loss of C-peptide during the first six years after type 1 diabetes (T1D) diagnosis is associated with a higher risk of severe...
Tzield, the World's First USFDA approved drug to delay type 1 diabetes onset to cost more than Rs 11 lakh per vial, confirm makers Ruchika Sharma19 Nov 2022 11:49 AM ISTNew Jersey: With the recent USFDA, approval of the first drug to delay type 1 diabetes onset, teplizumab, makers of the drug Provention Bio...
Tzield, first drug to delay type 1 diabetes onset, receives FDA approval Medha Baranwal19 Nov 2022 11:15 AM ISTTZIELD is the first disease-modifying therapy for type 1 diabetes, a life-threatening autoimmune disease.USA: Tzield (teplizumab-mzwv), an injection...
Microvascular complications have synergistic negative effect on all cause mortality among diabetics Medha Baranwal11 Nov 2022 9:15 AM ISTItaly: A recent study published in Cardiovascular Diabetology has shown the synergistic, long-term, and adverse effects of diabetic microvascular...
Assisted insulin delivery system improves postexercise nocturnal glycemic management in adults and adolescents Dr Kartikeya Kohli10 Nov 2022 10:00 AM ISTCanada: In adults and adolescents with type 1 diabetes, assisted insulin delivery (AID) systems improved nocturnal glycemic management in...
Neurological dysfunction tied to ischemic injury to kidneys in type 1 diabetes patients Medha Baranwal22 Oct 2022 9:00 AM ISTCanada: Neurological dysfunction in diabetes presence contributes to impaired renal blood flow and ischemic injury in patients with type 1 diabetes;...
